Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire)

Leto Olivier Gogbe; Thomas D’Aquin Toni; Jean-Jacques Renaud Dechi; Jean-Louis Philippe N’Din; Emmanuel Brou; Flore Fieni; Roland Aby; Kouadio Kouakou; Henri Chenal; Jean David N’Guessan

doi:doi:10.11648/j.ajbio.20210904.15

Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire)

Leto Olivier Gogbe, Thomas D’Aquin Toni, Jean-Jacques Renaud Dechi, Jean-Louis Philippe N’Din, Emmanuel Brou, Flore Fieni, Roland Aby, Kouadio Kouakou, Henri Chenal, Jean David N’Guessan

Published in American Journal of BioScience (Volume 9, Issue 4)

Received: 29 June 2021 Accepted: 15 July 2021 Published: 22 July 2021

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Liver disease is a major cause of morbidity and mortality among people living with HIV (PLWH). Diagnosis of these co-infections should be a priority in HIV-infected pregnant women so that they can receive appropriate and effective treatment. However, the prevalence of these infections in this vulnerable population remains poorly documented in Côte d'Ivoire. The objective of this study is to assess the seroprevalence of hepatitis B virus (HBV) or hepatitis C virus (HCV) co-infections in HIV-infected pregnant women undergoing ARV treatment in Abidjan (Côte d’Ivoire). A cross-sectional study among HIV-infected pregnant women was conducted from September 2017 to May 2018 in Abidjan. HBV and HCV serological tests were performed with the electrochemiluminescence method "ECLIA" on Cobas E 411. A total of one hundred (n = 100) HIV-infected pregnant women were included. The results showed that 6% (n=6/100) of the HIV-infected pregnant women had positive HBV serology and no HIV-HCV co-infection was detected. Of the 100 HIV-infected pregnant women included in this study, 23% had undergone surgery. In this population, HBsAg was positive in 9% of patients and HCV antibodies were negative in all patients. The data from this study support the implementation of large-scale sentinel surveillance in Côte d'Ivoire in order to refine data on the prevalence and circulation of viral hepatitis B and C in high-risk populations such as pregnant women.

Published in	American Journal of BioScience (Volume 9, Issue 4)
DOI	10.11648/j.ajbio.20210904.15
Page(s)	141-146
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2021. Published by Science Publishing Group

Keywords

HIV, HBV-HCV Coinfection, Prevalence, Pregnant Women

References

[1]	Silva, C. M., Peder, L. D., Guelere, A. M., Horvath, J. D., Silva, E. S., Teixeira, J. J., Bertolini, D. A. (2018). Seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) in human immunodeficiency virus (HIV)-infected patients in a HBV-endemic area in Brazil. PLoS ONE, 13 (9): e0203272.
[2]	Muriuki, B. M., Gicheru, M. M., Wachira, D., Nyamache, A. K. & Khamadi S. A. (2013). Prevalence of hepatitis B and C viral co-infections among HIV-1 infected individuals in Nairobi, Kenya. BMC Research Notes, 6: 363.
[3]	World Health Organization (2017). World Hepatitis Report, 2017. 2017. http://www.who.int/hepatitis/publications/global-hepatitis report2017.
[4]	Girard, P. M., Katlama, C. & Pialoux, G. (2011). HIV. 2011th ed. France: Rueil-Malmaison, 839 p.
[5]	National AIDS Control Program, (2015). 2015 uidelines for the care of people living with HIV in Côte d'Ivoire. 2015. https://aidsfree.usaid.gov/sites/default/files/ci_directives_2_2015_vih.pdf/ accessed on 05/19/2019.
[6]	Andersson, M. I., Maponga, T. G., Ijaz, S., Theron, G., Preiser, W. & Tedder, R. S. (2012). Elevated HBV viral loads in HIV-infected pregnant women in a tertiary hospital, South Africa. J Acquir Immune Defic Syndr. 60 (4): 2-111.
[7]	Boa, A., Douba, A., N'Guessan, T. B., Menan, H., Attia, A., Ouassa, T., Bénié, J. B., Abokon, A., Dosso, M., Aholi, P., Timité-Konan, M., Abauleth, R. Y., Bissagnéné, E., Aka, J., Yavo, J. C., Sylvain, B. J., Ouattara, GS, Ekra, D. K, Sow, K., Kouassi, J. N., Ahoussou, E. M., Dally, R. K. (2017). [An advocacy for the introduction of hepatitis B vaccination at birth in Côte d'Ivoire]. Public Health, 29 (5): 751-760.
[8]	Yeni P. (2018). Medical management of people living with HIV. Infections in adults: prophylaxis and curative treatments, www.corevih971.org/docrestreint.api/1789/.../pdf/experts-vih_infections-3.pdf. Accessed on 05/19/2019.
[9]	Mpody, C., Thompson, P., Tabala, M., Ravelomanana, N. L., Malongo, F., Kawende, B., Behets, F., Okitolonda, E., Yotebieng, M., (2019). CQI-PMTCT study team. Hepatitis B virus infection in pregnant and postpartum women living with HIV and on antiretroviral therapy in Kinshasa. antiretroviral therapy in Kinshasa, DR Congo: A cross-sectional study. PLoS One, 14 (5): e0216293.
[10]	UNAIDS, 2017. HIV Fact Sheets. http://aidsinfo.unaids.org/ accessed on 05/19/2019.
[11]	Yotebieng, M., Mpody, C., Ravelomanana, N. L., Tabala, M., Malongo, F., Kawende, B., Ntangu, P., Behets, F. & Okitolonda, E. (2019). HIV viral suppression among pregnant and breastfeeding women in routine care in the Kinshasa province: a baseline evaluation of participants in CQI-PMTCT study. Journal of the International AIDS Society, 22: 25376- 25386.
[12]	United Nations Organization on AIDS (UNAIDS), 2014. An ambitious treatment target to help end the AIDS epidemic Joint United Nations Programme on HIV/AIDS. 57 p.
[13]	World Health Organization. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV Infection. Available at: www.who.int. 2016. Accessed on 07/14/2022.
[14]	Rouet, F., Chaix, M. L., Inwoley, A., Msellati, P., Viho, I., Combe, P., Leroy, V., Dabis, F., Rouzioux, C. & ANRS 1236 DITRAME-B & C Study Group (2004). Prevalence and viremia of HBV and HCV in HIV-positive and HIV-negative pregnant women in Abidjan, Côte d'Ivoire: the ANRS 1236 study. J Med Virol, 74 (1): 34-40.
[15]	Mutagoma, M., Balisanga, H., Malamba, S. S., Sebuhoro, D., Remera, E., Riedel, D. J., Kanters, S. & Nsanzimana, S. (2017). Hepatitis B virus and HIV co-infection among pregnant women in Rwanda. BMC Infect Dis, 17 (1): 618.
[16]	Thumbiran, N. V., Moodley, D., Parboosing, R. & Moodley, P. (2014). Hepatitis B virus and HIV co-infection in pregnant women: indication for routine antenatal hepatitis B virus screening in a high HIV prevalence setting. S Afr Med J, 104 (4): 9-307.
[17]	Enel, C., Desgrées, du Lou A, N'Dri Y. T. & Daniel L. (2015). Viral hepatitis B and C in Côte d'Ivoire: the urgency of boosting control. African Journal of Hepato-Gastroenterology, 9 (3): 94-98.
[18]	Ekouevi, D. K., Coffie, P. A., Tchounga, B. K., Poda, A., Jaquet, A., Dabis, F. & Eholie, S. P. (2018). Prevalence of hepatitis C in HIV-1, HIV-2, and dual reactive patients: A multi-country cross-sectional survey in West Africa. J Public Health Afr, 9 (2): 871.
[19]	N’din, J. L., Toni, T. D., Dechi, J. J. R., N’Guessan, J. F., Gogbe, L. O., Brou, E., A. A., Kouakou,. K., Chenal, H., Camara, C. M. (2018). Molecular characterization of hepatitis C virus strain circulated in chronically infected patients in Abidjan (Cote d'Ivoire). International Journal of Biochemistry, Bioinformatics and Biotechnology Studies, 3 (2): 20-28.
[20]	Moufalilou, A. Aboudou, R. K. Bignon, R. G. Hermione Glago, Amel G. A. Zafy, H. M. & Jean S. (2020). Prevalence and factors associated with HCV antibody carriage in pregnant women in Cotonou. Pan African Medical Journal. 36: 182.
[21]	Collins, M. & Heptonstall, J. (1984). Occupational acquisition of acute hepatitis B infection by health care workers: England and Wales 1985-1993. Commun Dis Rep CDR Rev. 4: 153-5.
[22]	Minuk, GY, Cohen, AJ, Assy, N., & Moser, M. (2005). Viral hepatitis and the surgeon. HPB: the official journal of the International Hepato Pancreato Biliary Association, 7 (1), 56-64.
[23]	World Health Organization. GUIDELINES ON HEPATITIS B AND C TESTING FEBRUARY 2017. Available at: www.who.int. Accessed on 07/14/2022.

Cite This Article

Plain Text BibTeX RIS

APA Style

Leto Olivier Gogbe, Thomas D’Aquin Toni, Jean-Jacques Renaud Dechi, Jean-Louis Philippe N’Din, Emmanuel Brou, et al. (2021). Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire). American Journal of BioScience, 9(4), 141-146. https://doi.org/10.11648/j.ajbio.20210904.15

Copy | Download

ACS Style

Leto Olivier Gogbe; Thomas D’Aquin Toni; Jean-Jacques Renaud Dechi; Jean-Louis Philippe N’Din; Emmanuel Brou, et al. Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire). Am. J. BioScience 2021, 9(4), 141-146. doi: 10.11648/j.ajbio.20210904.15

Copy | Download

AMA Style

Leto Olivier Gogbe, Thomas D’Aquin Toni, Jean-Jacques Renaud Dechi, Jean-Louis Philippe N’Din, Emmanuel Brou, et al. Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire). Am J BioScience. 2021;9(4):141-146. doi: 10.11648/j.ajbio.20210904.15

Copy | Download

@article{10.11648/j.ajbio.20210904.15,
  author = {Leto Olivier Gogbe and Thomas D’Aquin Toni and Jean-Jacques Renaud Dechi and Jean-Louis Philippe N’Din and Emmanuel Brou and Flore Fieni and Roland Aby and Kouadio Kouakou and Henri Chenal and Jean David N’Guessan},
  title = {Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire)},
  journal = {American Journal of BioScience},
  volume = {9},
  number = {4},
  pages = {141-146},
  doi = {10.11648/j.ajbio.20210904.15},
  url = {https://doi.org/10.11648/j.ajbio.20210904.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbio.20210904.15},
  abstract = {Liver disease is a major cause of morbidity and mortality among people living with HIV (PLWH). Diagnosis of these co-infections should be a priority in HIV-infected pregnant women so that they can receive appropriate and effective treatment. However, the prevalence of these infections in this vulnerable population remains poorly documented in Côte d'Ivoire. The objective of this study is to assess the seroprevalence of hepatitis B virus (HBV) or hepatitis C virus (HCV) co-infections in HIV-infected pregnant women undergoing ARV treatment in Abidjan (Côte d’Ivoire). A cross-sectional study among HIV-infected pregnant women was conducted from September 2017 to May 2018 in Abidjan. HBV and HCV serological tests were performed with the electrochemiluminescence method "ECLIA" on Cobas E 411. A total of one hundred (n = 100) HIV-infected pregnant women were included. The results showed that 6% (n=6/100) of the HIV-infected pregnant women had positive HBV serology and no HIV-HCV co-infection was detected. Of the 100 HIV-infected pregnant women included in this study, 23% had undergone surgery. In this population, HBsAg was positive in 9% of patients and HCV antibodies were negative in all patients. The data from this study support the implementation of large-scale sentinel surveillance in Côte d'Ivoire in order to refine data on the prevalence and circulation of viral hepatitis B and C in high-risk populations such as pregnant women.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire)
AU  - Leto Olivier Gogbe
AU  - Thomas D’Aquin Toni
AU  - Jean-Jacques Renaud Dechi
AU  - Jean-Louis Philippe N’Din
AU  - Emmanuel Brou
AU  - Flore Fieni
AU  - Roland Aby
AU  - Kouadio Kouakou
AU  - Henri Chenal
AU  - Jean David N’Guessan
Y1  - 2021/07/22
PY  - 2021
N1  - https://doi.org/10.11648/j.ajbio.20210904.15
DO  - 10.11648/j.ajbio.20210904.15
T2  - American Journal of BioScience
JF  - American Journal of BioScience
JO  - American Journal of BioScience
SP  - 141
EP  - 146
PB  - Science Publishing Group
SN  - 2330-0167
UR  - https://doi.org/10.11648/j.ajbio.20210904.15
AB  - Liver disease is a major cause of morbidity and mortality among people living with HIV (PLWH). Diagnosis of these co-infections should be a priority in HIV-infected pregnant women so that they can receive appropriate and effective treatment. However, the prevalence of these infections in this vulnerable population remains poorly documented in Côte d'Ivoire. The objective of this study is to assess the seroprevalence of hepatitis B virus (HBV) or hepatitis C virus (HCV) co-infections in HIV-infected pregnant women undergoing ARV treatment in Abidjan (Côte d’Ivoire). A cross-sectional study among HIV-infected pregnant women was conducted from September 2017 to May 2018 in Abidjan. HBV and HCV serological tests were performed with the electrochemiluminescence method "ECLIA" on Cobas E 411. A total of one hundred (n = 100) HIV-infected pregnant women were included. The results showed that 6% (n=6/100) of the HIV-infected pregnant women had positive HBV serology and no HIV-HCV co-infection was detected. Of the 100 HIV-infected pregnant women included in this study, 23% had undergone surgery. In this population, HBsAg was positive in 9% of patients and HCV antibodies were negative in all patients. The data from this study support the implementation of large-scale sentinel surveillance in Côte d'Ivoire in order to refine data on the prevalence and circulation of viral hepatitis B and C in high-risk populations such as pregnant women.
VL  - 9
IS  - 4
ER  -

Copy | Download

Author Information

Leto Olivier Gogbe

Abidjan Integrated Centre for Bioclinical Research, Abidjan, C?te d'Ivoire
Thomas D’Aquin Toni

Abidjan Integrated Centre for Bioclinical Research, Abidjan, C?te d'Ivoire
Jean-Jacques Renaud Dechi

Abidjan Integrated Centre for Bioclinical Research, Abidjan, C?te d'Ivoire
Jean-Louis Philippe N’Din

Abidjan Integrated Centre for Bioclinical Research, Abidjan, C?te d'Ivoire
Emmanuel Brou

Abidjan Integrated Centre for Bioclinical Research, Abidjan, C?te d'Ivoire
Flore Fieni

Abidjan Integrated Centre for Bioclinical Research, Abidjan, C?te d'Ivoire
Roland Aby

Abidjan Integrated Centre for Bioclinical Research, Abidjan, C?te d'Ivoire
Kouadio Kouakou

Abidjan Integrated Centre for Bioclinical Research, Abidjan, C?te d'Ivoire
Henri Chenal

Abidjan Integrated Centre for Bioclinical Research, Abidjan, C?te d'Ivoire
Jean David N’Guessan

UFR Biosciences, Felix Houphou?t Boigny University, Abidjan, C?te d'Ivoire

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Leto Olivier Gogbe, Thomas D’Aquin Toni, Jean-Jacques Renaud Dechi, Jean-Louis Philippe N’Din, Emmanuel Brou, et al. (2021). Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire). American Journal of BioScience, 9(4), 141-146. https://doi.org/10.11648/j.ajbio.20210904.15

Copy | Download

ACS Style

Leto Olivier Gogbe; Thomas D’Aquin Toni; Jean-Jacques Renaud Dechi; Jean-Louis Philippe N’Din; Emmanuel Brou, et al. Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire). Am. J. BioScience 2021, 9(4), 141-146. doi: 10.11648/j.ajbio.20210904.15

Copy | Download

AMA Style

Leto Olivier Gogbe, Thomas D’Aquin Toni, Jean-Jacques Renaud Dechi, Jean-Louis Philippe N’Din, Emmanuel Brou, et al. Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire). Am J BioScience. 2021;9(4):141-146. doi: 10.11648/j.ajbio.20210904.15

Copy | Download

@article{10.11648/j.ajbio.20210904.15,
  author = {Leto Olivier Gogbe and Thomas D’Aquin Toni and Jean-Jacques Renaud Dechi and Jean-Louis Philippe N’Din and Emmanuel Brou and Flore Fieni and Roland Aby and Kouadio Kouakou and Henri Chenal and Jean David N’Guessan},
  title = {Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire)},
  journal = {American Journal of BioScience},
  volume = {9},
  number = {4},
  pages = {141-146},
  doi = {10.11648/j.ajbio.20210904.15},
  url = {https://doi.org/10.11648/j.ajbio.20210904.15},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajbio.20210904.15},
  abstract = {Liver disease is a major cause of morbidity and mortality among people living with HIV (PLWH). Diagnosis of these co-infections should be a priority in HIV-infected pregnant women so that they can receive appropriate and effective treatment. However, the prevalence of these infections in this vulnerable population remains poorly documented in Côte d'Ivoire. The objective of this study is to assess the seroprevalence of hepatitis B virus (HBV) or hepatitis C virus (HCV) co-infections in HIV-infected pregnant women undergoing ARV treatment in Abidjan (Côte d’Ivoire). A cross-sectional study among HIV-infected pregnant women was conducted from September 2017 to May 2018 in Abidjan. HBV and HCV serological tests were performed with the electrochemiluminescence method "ECLIA" on Cobas E 411. A total of one hundred (n = 100) HIV-infected pregnant women were included. The results showed that 6% (n=6/100) of the HIV-infected pregnant women had positive HBV serology and no HIV-HCV co-infection was detected. Of the 100 HIV-infected pregnant women included in this study, 23% had undergone surgery. In this population, HBsAg was positive in 9% of patients and HCV antibodies were negative in all patients. The data from this study support the implementation of large-scale sentinel surveillance in Côte d'Ivoire in order to refine data on the prevalence and circulation of viral hepatitis B and C in high-risk populations such as pregnant women.},
 year = {2021}
}

Copy | Download

TY  - JOUR
T1  - Seroprevalence of Viral Hepatitis B or Hepatitis C Infection in HIV-infected Pregnant Women on Antiretroviral Therapy (ARV) in Abidjan (Côte d'Ivoire)
AU  - Leto Olivier Gogbe
AU  - Thomas D’Aquin Toni
AU  - Jean-Jacques Renaud Dechi
AU  - Jean-Louis Philippe N’Din
AU  - Emmanuel Brou
AU  - Flore Fieni
AU  - Roland Aby
AU  - Kouadio Kouakou
AU  - Henri Chenal
AU  - Jean David N’Guessan
Y1  - 2021/07/22
PY  - 2021
N1  - https://doi.org/10.11648/j.ajbio.20210904.15
DO  - 10.11648/j.ajbio.20210904.15
T2  - American Journal of BioScience
JF  - American Journal of BioScience
JO  - American Journal of BioScience
SP  - 141
EP  - 146
PB  - Science Publishing Group
SN  - 2330-0167
UR  - https://doi.org/10.11648/j.ajbio.20210904.15
AB  - Liver disease is a major cause of morbidity and mortality among people living with HIV (PLWH). Diagnosis of these co-infections should be a priority in HIV-infected pregnant women so that they can receive appropriate and effective treatment. However, the prevalence of these infections in this vulnerable population remains poorly documented in Côte d'Ivoire. The objective of this study is to assess the seroprevalence of hepatitis B virus (HBV) or hepatitis C virus (HCV) co-infections in HIV-infected pregnant women undergoing ARV treatment in Abidjan (Côte d’Ivoire). A cross-sectional study among HIV-infected pregnant women was conducted from September 2017 to May 2018 in Abidjan. HBV and HCV serological tests were performed with the electrochemiluminescence method "ECLIA" on Cobas E 411. A total of one hundred (n = 100) HIV-infected pregnant women were included. The results showed that 6% (n=6/100) of the HIV-infected pregnant women had positive HBV serology and no HIV-HCV co-infection was detected. Of the 100 HIV-infected pregnant women included in this study, 23% had undergone surgery. In this population, HBsAg was positive in 9% of patients and HCV antibodies were negative in all patients. The data from this study support the implementation of large-scale sentinel surveillance in Côte d'Ivoire in order to refine data on the prevalence and circulation of viral hepatitis B and C in high-risk populations such as pregnant women.
VL  - 9
IS  - 4
ER  -

Copy | Download